射频消融在治疗甲状腺癌症状性远处转移中的作用
回顾性分析12例患者共18个甲状腺癌症状性远处转移灶的射频消融姑息治疗,其中软组织转移9个、骨转移9个,平均肿瘤大小5.3 cm;消融后61.1%的转移灶症状主观改善,9个肿瘤缩小、平均缩小比例43%±22%,无RFA相关主要不良事件;作者认为RFA可作为姑息治疗缓解症状,但对改善总体预后作用有限。
要点
- RFA可用于缓解甲状腺癌远处转移灶引起的疼痛、不适或肿块膨隆等症状。
- 消融后61.1%的转移灶报告症状主观改善,9/18个肿瘤缩小、平均缩小比例43%±22%。
- 平均随访37.4个月期间5例进展、4例稳定、3例死于肺炎,无RFA相关主要不良事件。
核心结论
- RFA可作为姑息治疗用于缓解转移性肿瘤引起的症状。
- RFA对改善甲状腺癌远处转移患者的总体预后作用有限。
研究设计与样本
- 回顾性分析2008年1月至2020年12月间接受RFA姑息治疗的12例甲状腺癌症状性远处转移患者的病历资料。
- 共治疗18个症状性远处转移灶,其中软组织转移9个、骨转移9个。
- 所有患者评估不适程度,并作为门诊患者定期接受临床检查、影像学和血清学标志物评估。
关键影像表现/征象
- 治疗肿瘤平均大小5.3 cm(范围1.7-10.7 cm)。
- 所有患者在RFA前均主诉疼痛、不适和/或转移肿块膨隆。
局限性
- RFA对改善甲状腺癌远处转移患者总体预后的作用有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the effectiveness and safety of radiofrequency ablation (RFA) for the treatment of symptomatic distant metastasis of differentiated thyroid carcinoma.
MATERIALS AND METHODS: The medical records of 12 patients who underwent RFA for the palliative treatment of 18 symptomatic distant metastases from thyroid cancer between January 2008 and December 2020 were analyzed. All patients were assessed for their degree of discomfort and underwent periodical evaluations as outpatients, including clinical examination, imaging, and serologic markers.
RESULTS: Among the 18 tumors treated, nine were soft tissue, and nine were bone metastases. The mean size of the treated tumors was 5.3 cm (range, 1.7-10.7 cm). All patients complained of pain, discomfort and/or bulging of the metastatic mass before RFA. After RFA, 11 out of the 18 patients with metastatic tumors (61.1%) reported a subjective improvement in symptoms. Nine out of 18 tumors decreased in size, with a mean size reduction ratio of 43% ± 22%. Although symptom improvement was achieved in 61.1% of the tumors, after a mean follow-up duration of 37.4 months, five patients experienced progression of the tumor, four patients had a stable tumor status, and three patients died from pneumonia. There were no major adverse events related to RFA during the treatment or follow-up period.
CONCLUSION: RFA can be used as palliative therapy to relieve the symptoms caused by metastatic tumors; however, it has a limited role in improving the overall prognosis in patients with distant metastasis from thyroid cancer.
引用
- Lee JH, Chung SR, Baek JH, et al. Role of radiofrequency ablation in the treatment of symptomatic distant metastasis of thyroid cancer. Skeletal Radiol. 2025. PMID: 39836186. doi:10.1007/s00256-025-04871-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。